A 71-year-old female with BRAF mutation–positive melanoma presented with metastases to the lungs, spleen, abdominal lymph nodes, sternum, right lateral sixth rib, and right ilium subsequent to disease progression on vemurafenib (Zelboraf). This evidence concerns the gene BRAF and melanoma.